Many studies have shown that the LPS/TLR4 signaling pathway mediates inflammation, oxidative stress, insulin resistance and liver fibrosis, and is one of the key factors in the pathology of NAFLD [36,37]. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.